BRD7 is associated with various types of cancer including melanoma, endometrial, and bladder cancer (Figure 2), and it has mostly been studied in the context of transcription and its association with p53 (Burrows et al., 2010; Yu et al., 2016). Here, BRD7 is linked to melanoma.